Janet Rae
Conseiller Juridique Général chez APPLIED GENETIC TECHNOLOGIES CORPORATION
Postes actifs de Janet Rae
Sociétés | Poste | Début | Fin |
---|---|---|---|
APPLIED GENETIC TECHNOLOGIES CORPORATION | Conseiller Juridique Général | 18/06/2021 | - |
Historique de carrière de Janet Rae
Anciens postes connus de Janet Rae
Sociétés | Poste | Début | Fin |
---|---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/11/2017 | 01/06/2021 |
DIMENSION THERAPEUTICS INC | Conseiller Juridique Général | 01/09/2015 | - |
Formation de Janet Rae
Gordon College (Georgia) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
General Counsel | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |